Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Accessibility to TAVI in a center without cardiac surgery : a Corsican example].

Annales de cardiologie et d'angeiologie·2025
Same author

From discovery to surgery: A case report on an extremely rare coronaro-cava fistula.

Heliyon·2024
Same author

Dispersal capacities of pollen, seeds and spores: insights from comparative analyses of spatial genetic structures in bryophytes and spermatophytes.

Frontiers in plant science·2023
Same author

Disentangling the roles of chance, abiotic factors and biotic interactions among epiphytic bryophyte communities in a tropical rainforest (Yunnan, China).

Plant biology (Stuttgart, Germany)·2023
Same author

Five-year outcomes of rapid-deployment aortic valve replacement with the Edwards Intuity valve.

Journal of cardiac surgery·2021
Same author

[COVID-19 inside dialysis units].

Revue medicale de Liege·2020
Same journal

[Respiratory Medicine and Research: The new SPLF's anglophone journal].

Revue de pneumologie clinique·2018
Same journal

[Medical journals publication: Let's change].

Revue de pneumologie clinique·2018
Same journal

[Multiple ulcerated tracheobronchial mucosal lesions in the eosinophilic granulomatosis with polyangiitis].

Revue de pneumologie clinique·2018
Same journal

[Medium and long-term respiratory outcome in patients operated from congenital diaphragmatic hernia: From a series of 56 patients].

Revue de pneumologie clinique·2018
Same journal

[Sporadic lymphangioleiomyomatosis: A rare cause of bilateral spontaneous pneumothorax in young woman].

Revue de pneumologie clinique·2018
Same journal

[COPD and smoking cessation: Patients' expectations and responses of health professionals].

Revue de pneumologie clinique·2018
See all related articles

Related Experiment Video

Updated: Jun 15, 2026

Ultrasound Imaging-guided Intracardiac Injection to Develop a Mouse Model of Breast Cancer Brain Metastases Followed by Longitudinal MRI
08:36

Ultrasound Imaging-guided Intracardiac Injection to Develop a Mouse Model of Breast Cancer Brain Metastases Followed by Longitudinal MRI

Published on: March 6, 2014

[Cardiac tumors].

A Riberi1, V Gariboldi, D Grisoli

  • 1Service de Chirurgie Cardiaque Adulte, Hôpital de la Timone, 264 rue Saint-Pierre, 13005 Marseille, France.

Revue De Pneumologie Clinique
|March 9, 2010
PubMed
Summary
This summary is machine-generated.

Primary cardiac tumors are rare, with most being benign myxomas. Treatment varies by tumor type, with surgery for benign or localized malignant tumors, and chemotherapy/radiotherapy for widespread disease or lymphoma.

More Related Videos

Cardiac Magnetic Resonance for the Evaluation of Suspected Cardiac Thrombus: Conventional and Emerging Techniques
06:29

Cardiac Magnetic Resonance for the Evaluation of Suspected Cardiac Thrombus: Conventional and Emerging Techniques

Published on: June 11, 2019

Related Experiment Videos

Last Updated: Jun 15, 2026

Ultrasound Imaging-guided Intracardiac Injection to Develop a Mouse Model of Breast Cancer Brain Metastases Followed by Longitudinal MRI
08:36

Ultrasound Imaging-guided Intracardiac Injection to Develop a Mouse Model of Breast Cancer Brain Metastases Followed by Longitudinal MRI

Published on: March 6, 2014

Cardiac Magnetic Resonance for the Evaluation of Suspected Cardiac Thrombus: Conventional and Emerging Techniques
06:29

Cardiac Magnetic Resonance for the Evaluation of Suspected Cardiac Thrombus: Conventional and Emerging Techniques

Published on: June 11, 2019

Area of Science:

  • Cardiology
  • Oncology

Context:

  • Primary cardiac tumors are rare, affecting 0.001-0.03% of the population.
  • Benign tumors constitute 80% of primary cardiac tumors, with myxomas being the most common (70%).
  • Cardiac metastases are more frequent than primary cardiac tumors.

Purpose:

  • To provide an overview of primary cardiac tumors, including their incidence, types, diagnosis, treatment, and prognosis.
  • To differentiate between benign and malignant primary cardiac tumors.
  • To highlight the diagnostic modalities and therapeutic strategies for cardiac tumors.

Summary:

  • Eighty percent of primary cardiac tumors are benign, predominantly myxomas. Malignant tumors are typically sarcomas (95%) or lymphomas (5%).
  • Diagnosis relies on echocardiography, CT angiography (TAC), and MRI.
  • Treatment strategies include surgery for benign or localized sarcomas, chemotherapy for widespread disease, and combined radiotherapy and chemotherapy for lymphoma.

Impact:

  • Prognosis is excellent for benign cardiac tumors.
  • Mean survival for sarcomas is 11 months, and for lymphoma is 5 years.
  • Understanding tumor characteristics is crucial for effective treatment planning and patient outcomes.